Article Text
Abstract
Introduction Future HIV vaccine efficacy trials with adolescents will need to ensure that participants comprehend study concepts in order to confer true informed assent. A Hepatitis B vaccine trial with adolescents offers valuable opportunity to test youth understanding of vaccine trial requirements in general.
Methods Youth reviewed a simplified assent form with study investigators and then completed a comprehension questionnaire. Once enrolled, all youth were tested for HIV and confirmed to be HIV-negative.
Results 123 youth completed the questionnaire (mean age=15 years; 63% male; 70% Hispanic). Overall, only 69 (56%) youth answered all six questions correctly.
Conclusions Youth enrolled in a Hepatitis B vaccine trial demonstrated variable comprehension of the study design and various methodological concepts, such as treatment group masking.
- Informed Consent
- HIV Infection and AIDS
- Minors/Parental Consent
- Clinical trials
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS)
- Preventive misconception and adolescents’ knowledge about HIV vaccine trials
- Ethics, human rights and HIV vaccine trials in low-income settings
- P306 Vaccine development & AMP; participation in sub saharan africa: how willing are young people in western nigeria?
- P6.01 Knowledge and attitude towards hiv vaccine trial concepts among youth of mangalore city
- P2-S1.06 Adolescents' willingness to participate in HIV vaccine clinical trial preparedness in Nigeria
- Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine
- Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance
- Improving adherence to hepatitis B vaccine administration recommendations in two newborn nurseries
- First trial of the HIV-1 vaccine in Africa: Ugandan experience